 MINNEAPOLIS, Aug. 11, 2021 GLOBE NEWSWIRE -- Predictive Oncology Nasdaq: POAI, a knowledge-driven company focused on applying artificial intelligence AI to personalized medicine and drug discovery, announced today that the Companys Special Meeting of Stockholders, which was convened at 3:00 p.m. Central Time on August 10, 2021, has been adjourned for the purpose of soliciting more votes on the proposal to approve an amendment to the Companys certificate of incorporation to increase the number of authorized shares of Company common stock from 100,000,000 to 200,000,000 the Charter Proposal. The Special Meeting has been scheduled to reconvene on August 17, 2021 at 3:00 p.m. Central time at the offices of Maslon LLP, 3300 Wells Fargo Center, 90 South Seventh Street, Minneapolis, MN 55402. 